Surgical Innovations (GB:SUN)
LSE:SUN
Want to see GB:SUN full AI Analyst Report?
Total Valuation
Surgical Innovations has a market cap or net worth of £4.20M. The enterprise value is 4.05M .
Market Cap£4.20M
Enterprise Value4.05M
Share Statistics
Surgical Innovations has 932,816,160 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding932,816,160
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Surgical Innovations’s return on equity (ROE) is -0.12 and return on invested capital (ROIC) is -8.08%.
Return on Equity (ROE)-0.12
Return on Assets (ROA)-0.08
Return on Invested Capital (ROIC)-8.08%
Return on Capital Employed (ROCE)-0.09
Revenue Per Employee145.03K
Profits Per Employee-11.19K
Employee Count80
Asset Turnover1.00
Inventory Turnover3.90
Valuation Ratios
The current PE Ratio of Surgical Innovations is ―. Surgical Innovations’s PEG ratio is 0.09.
PE Ratio―
PS Ratio0.36
PB Ratio0.55
Price to Fair Value0.55
Price to FCF8.26
Price to Operating Cash Flow7.24
PEG Ratio0.09
Income Statement
In the last 12 months, Surgical Innovations had revenue of 11.60M and earned -895.00K in profits. Earnings per share was >-0.01.
Revenue11.60M
Gross Profit3.05M
Operating Income-731.00K
Pretax Income-944.00K
Net Income-895.00K
EBITDA-73.00K
Earnings Per Share (EPS)>-0.01
Cash Flow
In the last 12 months, operating cash flow was 569.00K and capital expenditures -61.00K, giving a free cash flow of 508.00K billion.
Operating Cash Flow569.00K
Free Cash Flow508.00K
Free Cash Flow per Share<0.01
Dividends & Yields
Surgical Innovations pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.13
52-Week Price Change-18.18%
50-Day Moving Average0.45
200-Day Moving Average0.56
Relative Strength Index (RSI)<0.01
Average Volume (3m)179.78K
Important Dates
Surgical Innovations upcoming earnings date is Sep 16, 2026, TBA (Confirmed).
Last Earnings DateApr 21, 2026
Next Earnings DateSep 16, 2026
Ex-Dividend Date―
Financial Position
Surgical Innovations as a current ratio of 1.48, with Debt / Equity ratio of 8.70%
Current Ratio1.48
Quick Ratio0.85
Debt to Market Cap0.09
Net Debt to EBITDA2.03
Interest Coverage Ratio-11.08
Taxes
In the past 12 months, Surgical Innovations has paid -49.00K in taxes.
Income Tax-49.00K
Effective Tax Rate0.05
Enterprise Valuation
Surgical Innovations EV to EBITDA ratio is -55.47, with an EV/FCF ratio of 7.97.
EV to Sales0.35
EV to EBITDA-55.47
EV to Free Cash Flow7.97
EV to Operating Cash Flow7.12
Balance Sheet
Surgical Innovations has £813.00K in cash and marketable securities with £665.00K in debt, giving a net cash position of £148.00K billion.
Cash & Marketable Securities£813.00K
Total Debt£665.00K
Net Cash£148.00K
Net Cash Per Share<£0.01
Tangible Book Value Per Share<£0.01
Margins
Gross margin is 26.31%, with operating margin of -6.30%, and net profit margin of -7.71%.
Gross Margin26.31%
Operating Margin-6.30%
Pretax Margin-8.14%
Net Profit Margin-7.71%
EBITDA Margin-0.63%
EBIT Margin-6.30%
Analyst Forecast
The average price target for Surgical Innovations is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-2.87%
EPS Growth Forecast52.38%